INSM(Insmed Incorporated) · 财务报表

INSM(Insmed Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$188.46M$245.36M$305.21M$363.71M$606.42M
毛利润$144.31M$190.23M$239.63M$277.96M$483.49M
营业利润−$375.09M−$457.32M−$709.63M−$878.25M−$1.25B
净利润−$434.65M−$481.53M−$749.57M−$913.77M−$1.28B
经营现金流−$363.30M−$400.44M−$536.25M−$683.88M−$935.01M
自由现金流−$370.59M−$410.32M−$549.53M−$705.80M−$967.58M
摊薄每股收益$-3.88$-3.91$-5.34$-5.57$-6.42

Insmed Incorporated INSM